[HTML][HTML] HIF-1-VEGF-Notch mediates angiogenesis in temporomandibular joint osteoarthritis

Y Chen, B Zhao, Y Zhu, H Zhao… - American journal of …, 2019 - ncbi.nlm.nih.gov
Y Chen, B Zhao, Y Zhu, H Zhao, C Ma
American journal of translational research, 2019ncbi.nlm.nih.gov
Angiogenesis has been reported participated in temporomandibular joint osteoarthritis (TMJ-
OA). While the pathogenesis is unclear, recent studies indicate that hypoxia is important in
TMJ-OA. In order to induce osteoarthritis-like lesions in mandibular condyles, rats were
sleep deprived experimentally. An increased number of blood vessels were observed in the
rats' condyles of SD and SR group compared with controls. Protein and mRNA levels of
related factors including VEGF, HIF-1 and Notch were investigated by means of …
Abstract
Angiogenesis has been reported participated in temporomandibular joint osteoarthritis (TMJ-OA). While the pathogenesis is unclear, recent studies indicate that hypoxia is important in TMJ-OA. In order to induce osteoarthritis-like lesions in mandibular condyles, rats were sleep deprived experimentally. An increased number of blood vessels were observed in the rats’ condyles of SD and SR group compared with controls. Protein and mRNA levels of related factors including VEGF, HIF-1 and Notch were investigated by means of immunohistochemical staining, western blot and real-time PCR, which were highly expressed in the TMJ-OA rats. Furthermore, Cell test was designed to study effects of hypoxia on condylar chondrocytes. We found the expression of VEGF, HIF-1 and Notch were significantly increased in hypoxia group, indicating that HIF-1-Notch-VEGF signaling pathway were activated by hypoxia. The inhibitors of HIF-1 and Notch could suppress the expression of HIF-1, VEGF, Notch, suggesting the HIF-1-VEGF-Notch signaling pathway were bidirectional. Together, hypoxia played an important role in TMJ-OA and accelerates angiogenesis of condylar cartilage through HIF-1-VEGF-Notch signaling pathway. HIF-1α and Notch might be novel therapeutic targets in TMJ-OA.
ncbi.nlm.nih.gov